Marshall, Gerstein & Borun LLP Wins Three LMG Life Sciences Awards

September 23, 2014

Marshall, Gerstein & Borun LLP is pleased to announce the Firm was honored in three distinct categories at the second annual LMG Life Sciences Awards ceremony held September 17, 2014, in New York City. The celebration recognizes the very best life science practitioners and firms over the past 12 months from the United States, Canada and Europe. Awards garnered include:

  • LMG Life Sciences Hall of Fame Inductee – Li-Hsien (Lily) Rin-Laures, M.D.
  • Patent Prosecution Pharmaceutical Attorney of the Year – Li-Hsien (Lily) Rin-Laures, M.D.
  • Hatch Waxman Impact Case of the YearPfizer Inc. and Northwestern University v. Teva Pharms., et al. – Case team members: Kevin M. Flowers, Ph.D., Mark H. Izraelewicz and Matthew C. Nielsen

For clients in the biopharma industry, Li-Hsien (Lily) Rin-Laures, M.D. is a strategic partner who uses intellectual property to achieve her clients’ business goals. Dr. Rin-Laures, a former General Counsel of a publicly-held biotechnology company, regularly counsels clients - from Fortune 500 companies to startups - on patent strategy relating to new pharmaceutical/biotechnology product development, therapeutic uses, and product lifecycle management, as well as the interface with FDA regulations and related exclusivity provisions. Her unique insider’s perspective, technical experience, and wide-ranging industry knowledge acquired from managing global patent portfolios for eight different approved drugs and numerous clinical trial candidates enables her to be a valuable strategic partner to clients.

Marshall, Gerstein & Borun partners Kevin M. Flowers, Ph.D., Mark H. Izraelewicz and Matthew C. Nielsen represented Northwestern University in a Hatch-Waxman suit against Teva Pharmaceuticals, in which seven generic drug companies sought to market generic versions of Lyrica®, a drug that has its origin in the research of a Northwestern University chemist. The Firm successfully represented Northwestern first in its claim that the patents covering the active ingredient in Lyrica® were valid, and again when the generic companies appealed the initial ruling.

The LMG Life Sciences award nominations are based on research and submissions undertaken by the editors of Euromoney’s 2014 LMG Life Sciences guide, which is aimed at providing attorneys and law firms with information on the legal market and the U.S. life sciences industry. Research for the entire publication was based on reviewing nearly 1,000 interviews and surveys completed by partners active in the market. In the 2013 LMG Life Sciences guide, Marshall, Gerstein & Borun was "highly recommended" for patent prosecution and "highly recommended" for patent strategy and management.

In 2014, Marshall, Gerstein & Borun LLP was shortlisted in 10 categories for the LMG Life Sciences Awards. Additionally, managing partner Jeffrey S. Sharp and partners Pamela L. Cox, David A. Gass, Michael Muczynski, and Li-Hsien (Lily) Rin-Laures, M.D. were named as 2014 Life Sciences Stars, consistently recommended as reputable and effective attorneys servicing the industry.

Marshall, Gerstein & Borun LLP, founded in 1955, is exclusively focused on intellectual property law, and protects, enforces, and transfers the intellectual property of its clients worldwide. The Firm delivers perspective and guidance where science, technology, and law converge. Nearly half of the Firm’s professionals have been in-house as general counsel, patent counsel, technology transfer managers, scientists, engineers, or consultants. The Firm’s professionals offer depth of talent and seasoned experience in devising and executing intellectual property strategy and comprehensive IP solutions.